---
title: "GF Securities Remains a Buy on Duality Biotherapeutics, Inc. (9606)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282293500.md"
description: "In a report released yesterday, from GF Securities maintained a Buy rating on Duality Biotherapeutics, Inc., with a price target of HK$520.49.Easter Sale - 70% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks Currently, the analyst consensus on Duality Biotherapeutics, Inc. is a Strong Buy with an average price target of HK$423.73."
datetime: "2026-04-10T05:36:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282293500.md)
  - [en](https://longbridge.com/en/news/282293500.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282293500.md)
---

# GF Securities Remains a Buy on Duality Biotherapeutics, Inc. (9606)

In a report released yesterday, from GF Securities maintained a Buy rating on Duality Biotherapeutics, Inc., with a price target of HK$520.49.

### Easter Sale - 70% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Currently, the analyst consensus on Duality Biotherapeutics, Inc. is a Strong Buy with an average price target of HK$423.73.

### Related Stocks

- [09606.HK](https://longbridge.com/en/quote/09606.HK.md)
- [588860.CN](https://longbridge.com/en/quote/588860.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [516820.CN](https://longbridge.com/en/quote/516820.CN.md)
- [513700.CN](https://longbridge.com/en/quote/513700.CN.md)
- [513120.CN](https://longbridge.com/en/quote/513120.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [560600.CN](https://longbridge.com/en/quote/560600.CN.md)
- [513060.CN](https://longbridge.com/en/quote/513060.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)

## Related News & Research

- [Analyst Reiterates Buy on Microbix, Citing Temporary China Slowdown and Growing Diversified Demand](https://longbridge.com/en/news/286665358.md)
- [Ab&B Bio-Tech Starts Early-Stage Trials for High-Yield RSV Vaccine as Trading Remains Suspended](https://longbridge.com/en/news/286268861.md)
- [HBM Holdings Says Director Probed by CSRC, Sees No Impact on Operations](https://longbridge.com/en/news/286197909.md)
- [20:03 ETHarbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate](https://longbridge.com/en/news/286688082.md)
- [Manulife Singapore to offer multi-cancer blood test starting May](https://longbridge.com/en/news/286710691.md)